Z-1923-2026 Class II Ongoing
FDA device recall Z-1923-2026 was initiated by Remel Europe Ltd. on Mar 25, 2026 and is designated Class II. Reason for recall: Affected lots are not performing to IFU criteria showing cross reactions with 2-0 within 60 seconds. Cross-reactivity may result in the misidentification of a Salmonella 9-O serotype as a 2-O… The recall status is ongoing. Affected quantity: 117 US; 950 OUS.
Recall details
- Product Type
- Devices
- Report Date
- Apr 29, 2026
- Initiation Date
- Mar 25, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 117 US; 950 OUS
Product description
Oxoid Agglutinating Sera, Salmonella 9-0 R30957301
Reason for recall
Affected lots are not performing to IFU criteria showing cross reactions with 2-0 within 60 seconds. Cross-reactivity may result in the misidentification of a Salmonella 9-O serotype as a 2-O serotype.
Distribution pattern
Worldwide - US Nationwide distribution to the states of AL, CA, FL, IA, IL, IN, MI, MN, MO, NC, NE, OH, SD, TX, WA.
Code information
UDI-DI 05056080500270 lots 6172600, 6172741, 6171393, 6150168, 6107767, 3766399, 3766400, 3780497, 3719592, 3709358, 6266130, 6253410, 6260215, 6222350, 6233859, 6233858
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1923-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026